You are here

Philip J. Rosenthal, MD

Global Health Sciences Faculty Affiliate

Phone: 415-206-8845
UCSF Box: 0811
Email: [email protected]
UCSF Profile

Archived

Project	Sponsor	Location(s)	Topics	Start	End
Global Malaria Prevention and Control	University of California Berkeley	Uganda	Malaria	10/1/01	9/30/04
Novel Tetracyclines as Antimalarial Agents	Paratek Pharmaceuticals, Inc.	United States	Malaria, Drug and Diagnostics Development	4/1/04	12/21/04
Evaluation of Falcipain as an Antimalarial Drug Target	NIH National Institute of Allergy and Infectious Disease	United States	Malaria	7/1/99	6/30/05
Novel Tetracyclines as Antimalarial Agents	Paratek Pharmaceuticals, Inc.	United States	Malaria, Drug and Diagnostics Development	4/1/04	3/31/06
Development and Testing of New Medications for the Treatment of Emerging Infectious Diseases [I]	University of Mississippi	United States	Infectious Disease, Drug and Diagnostics Development	9/15/02	9/14/06
Training In Malaria Research in Uganda	NIH John F. Fogarty International Center	Uganda	Malaria, Training and Capacity Building	9/29/00	2/28/08
Falcipain Cysteine Proteases of Malaria Parasites	NIH National Institute of Allergy and Infectious Disease	United States	Malaria	6/1/05	5/31/08
Development of Falcipain Inhibitors as Antimalarial Drugs	Medicines for Malaria Venture	United States	Malaria, Drug and Diagnostics Development	7/15/01	6/30/09
A Prospective Cohort Study of the association between HIV and Malaria Incidence and Response to Antimalarial Therapy in African Children	Arnold P. Gold Foundation, The	Uganda	HIV/AIDS, Malaria, Pediatrics	7/1/08	6/30/09
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies	NIH National Institute of Allergy and Infectious Disease	Uganda	Malaria	8/1/08	7/31/09
Clinical and Molecular Studies of Drug Resistant Malaria [I]	NIH National Institute of Allergy and Infectious Disease	Uganda	Malaria	8/15/03	2/28/10
Training In Malaria Research in Uganda	NIH John F. Fogarty International Center	Uganda	Malaria, Training and Capacity Building	9/16/05	3/31/11
Functional Outcomes in Pediatric Liver Transplantion	Lurie Children's Hospital of Chicago	United States	Pediatrics	4/1/05	3/31/11
Development and Testing of New Medications for the Treatment of Emerging Infectious Diseases [II]	University of Mississippi	United States	Infectious Disease, Neglected Tropical Diseases (NTDs), Malaria	9/30/06	9/29/11
Discovery of Oxaboroles as New Antimalarial Agents	NIH National Institute of Allergy and Infectious Disease	United States	Malaria	9/30/11	9/29/12
Translational Studies of Antimalarial Drug Resistance	Doris Duke Charitable Foundation	Uganda	Zoonosis, Emerging Disease, and Drug Resistance, Malaria	12/15/04	12/14/12
Berkeley Minority Health/Global Health (MH/GH) Training Program	University of California Berkeley	Kenya; Tanzania; India	Training and Capacity Building	12/1/12	11/30/13
Comparison of Home-Based Management of Fever/Malaria to Enhanced Health Facility-Based Care in Tororo, Uganda	London School of Hygiene & Tropical Medicine	Uganda	Malaria	3/1/09	12/31/13
Chemicals with Potential Activity against Malaria Parasites	Pharmadyn, Inc.		Malaria, Drug and Diagnostics Development	6/22/09	6/21/14
Etiology of Non-Malarial Febrile Illnesses in Ugandan Children	Doris Duke Charitable Foundation	Uganda	Malaria, Pediatrics	6/1/13	11/30/14
Training in Malaria Research in Uganda	NIH John F. Fogarty International Center	Uganda	Malaria, Training and Capacity Building	6/1/10	6/3/15
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies	NIH National Institute of Allergy and Infectious Disease	Uganda; Burkina Faso	Zoonosis, Emerging Disease, and Drug Resistance, Malaria	7/15/09	6/30/15
Discovery of benzoxaboroles for the treatment of cryptosporidiosis	Anacor Pharmaceuticals, Inc.	United States	Infectious Disease, Drug and Diagnostics Development	10/20/14	10/19/15
Fighting emerging antimalarial drug resistance	University of Melbourne, The	Australia	Zoonosis, Emerging Disease, and Drug Resistance, Malaria	1/1/14	12/31/16
Development of Antimalarial Drug Leads Through Inhibition of Food Vacuole Falcipains	University of Sydney	Australia	Malaria, Drug and Diagnostics Development	1/1/14	12/31/16
Discovery of Oxaboroles as New Antimalarial Agents	NIH National Institute of Allergy and Infectious Disease	United States	Malaria	4/1/12	3/31/17
Berkeley's Minority Health/Global Health Training Program	University of California Berkeley	United States	Neglected Tropical Diseases (NTDs), HIV/AIDS, Malaria, Residencies, Fellowships, and Postdoctoral Training	12/1/13	11/30/18
Discovery of Oxaboroles as New Antimalarial Agents	NIH National Institute of Allergy and Infectious Disease	Uganda	Malaria, Drug and Diagnostics Development	4/1/16	3/31/19
A Multi-Centric Evaluation of a Device for Automated Malaria Microscopy (EasyScan Go)	University of Oxford	Kenya; Uganda; Tanzania; South Africa; Burkina Faso; Senegal; Bangladesh; Cambodia; Indonesia; Myanmar; Thailand; Brazil	Malaria, Drug and Diagnostics Development	7/20/18	5/31/19
Resistance of Malaria Parasites to Artemisinin-Based Therapies	NIH National Institute of Allergy and Infectious Disease	Uganda	Zoonosis, Emerging Disease, and Drug Resistance, Malaria	12/1/14	11/30/20
Training in Malaria Research in Uganda	NIH John F. Fogarty International Center	Uganda	Malaria, Training and Capacity Building, Training International Scholars and Clinicians	6/4/15	1/31/21
Pharmacodynamics of Antimalarial Chemoprevention	NIH National Institute of Allergy and Infectious Disease	Uganda	Malaria, Pharmacology and Drug Treatment	2/10/15	1/31/21

Global Research Projects

Search form

You are here

Philip J. Rosenthal, MD

Browse more Investigators by location:

Browse more Investigators by topic:

Is your project missing or mislabeled?